Pharmaceutical Investing Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for Bertilimumab for the Treatment of Bullous Pemphigoid
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery